$271.91
0.04%
NYSE, Sep 28, 04:00 pm EDT. Closed.
ISIN
US1255231003
Symbol
CI

Cigna Target price 2026 - Analyst rating & recommendation

Cigna Classifications & Recommendation

Buy
76%
Hold
24%

Cigna Price Target

Target Price $346.80
Price $271.83
Potential
Number of Estimates 29
29 Analysts have issued a price target Cigna 2027 . The average Cigna target price is $346.80. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 34 analysts: 26 Analysts recommend Cigna to buy, 8 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Cigna stock has an average upside potential 2027 of . Most analysts recommend the Cigna stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 274.90 296.16
11.24% 7.73%
EBITDA Margin 4.37% 4.64%
5.32% 6.28%
Net Margin 2.17% 2.80%
55.94% 29.21%

29 Analysts have issued a sales forecast Cigna 2026 . The average Cigna sales estimate is

$296b
unlock
. This is
4.88% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$306b 8.43%
unlock
, the lowest is
$276b 2.30%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $275b 11.24%
2026
$296b 7.73%
unlock
2027
$309b 4.36%
unlock
2028
$327b 5.69%
unlock
2029
$333b 1.97%
unlock
2030
$348b 4.32%
unlock
2031
$361b 3.84%
unlock
2032
$375b 3.94%
unlock
2033
$389b 3.84%
unlock

22 Analysts have issued an Cigna EBITDA forecast 2026. The average Cigna EBITDA estimate is

$13.7b
unlock
. This is
8.73% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$15.7b 23.84%
unlock
, the lowest is
$11.4b 10.08%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $12.0b 5.33%
2026
$13.7b 14.56%
unlock
2027
$14.7b 6.82%
unlock
2028
$15.4b 4.66%
unlock
2029
$15.5b 0.66%
unlock
2030
$15.4b 0.17%
unlock
2031
$17.0b 10.11%
unlock
2032
$17.4b 2.22%
unlock
2033
$17.8b 2.22%
unlock

EBITDA Margin

2025 4.37% 5.32%
2026
4.64% 6.28%
unlock
2027
4.75% 2.37%
unlock
2028
4.71% 0.84%
unlock
2029
4.64% 1.49%
unlock
2030
4.44% 4.31%
unlock
2031
4.71% 6.08%
unlock
2032
4.63% 1.70%
unlock
2033
4.56% 1.51%
unlock

30 Cigna Analysts have issued a net profit forecast 2026. The average Cigna net profit estimate is

$8.3b
unlock
. This is
29.10% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$8.5b 32.53%
unlock
, the lowest is
$7.8b 22.24%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $6.0b 73.47%
2026
$8.3b 39.04%
unlock
2027
$9.1b 9.86%
unlock
2028
$10.1b 10.56%
unlock
2029
$11.2b 11.75%
unlock
2030
$12.4b 9.87%
unlock
2031
$13.5b 9.32%
unlock
2032
$14.8b 9.31%
unlock
2033
$16.1b 9.40%
unlock

Net Margin

2025 2.17% 55.94%
2026
2.80% 29.21%
unlock
2027
2.94% 5.00%
unlock
2028
3.08% 4.76%
unlock
2029
3.38% 9.74%
unlock
2030
3.55% 5.03%
unlock
2031
3.74% 5.35%
unlock
2032
3.94% 5.35%
unlock
2033
4.15% 5.33%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 22.18 31.41
83.00% 41.61%
P/E 8.65
EV/Sales 0.33

30 Analysts have issued a Cigna forecast for earnings per share. The average Cigna EPS is

$31.41
unlock
. This is
29.26% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$32.25 32.72%
unlock
, the lowest is
$29.74 22.39%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $22.18 83.00%
2026
$31.41 41.61%
unlock
2027
$34.51 9.87%
unlock
2028
$38.15 10.55%
unlock
2029
$42.64 11.77%
unlock
2030
$46.85 9.87%
unlock
2031
$51.21 9.31%
unlock
2032
$55.98 9.31%
unlock
2033
$61.24 9.40%
unlock

P/E ratio

Current 11.19 26.86%
2026
8.65 22.67%
unlock
2027
7.88 8.90%
unlock
2028
7.12 9.64%
unlock
2029
6.38 10.39%
unlock
2030
5.80 9.09%
unlock
2031
5.31 8.45%
unlock
2032
4.86 8.47%
unlock
2033
4.44 8.64%
unlock

Based on analysts' sales estimates for 2026, the Cigna stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.34 12.82%
2026
0.33 4.21%
unlock
2027
0.31 4.21%
unlock
2028
0.30 5.38%
unlock
2029
0.29 1.93%
unlock
2030
0.28 4.15%
unlock
2031
0.27 3.68%
unlock
2032
0.26 3.82%
unlock
2033
0.25 3.70%
unlock

P/S ratio

Current 0.25 12.73%
2026
0.24 4.68%
unlock
2027
0.23 4.16%
unlock
2028
0.22 5.38%
unlock
2029
0.22 1.96%
unlock
2030
0.21 4.13%
unlock
2031
0.20 3.73%
unlock
2032
0.19 3.77%
unlock
2033
0.18 3.71%
unlock

Current Cigna Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Jefferies
Locked
➜
Locked
Locked Aug 04 2026
Raymond James
Locked
➜
Locked
Locked Aug 03 2026
Wells Fargo
Locked
➜
Locked
Locked Jul 31 2026
Guggenheim
Locked
➜
Locked
Locked Jul 31 2026
Barclays
Locked
➜
Locked
Locked Jul 31 2026
Bernstein
Locked
➜
Locked
Locked Jul 09 2026
Mizuho
Locked
➜
Locked
Locked Jun 08 2026
Analyst Rating Date
Locked
Jefferies:
Locked
➜
Locked
Aug 04 2026
Locked
Raymond James:
Locked
➜
Locked
Aug 03 2026
Locked
Wells Fargo:
Locked
➜
Locked
Jul 31 2026
Locked
Guggenheim:
Locked
➜
Locked
Jul 31 2026
Locked
Barclays:
Locked
➜
Locked
Jul 31 2026
Locked
Bernstein:
Locked
➜
Locked
Jul 09 2026
Locked
Mizuho:
Locked
➜
Locked
Jun 08 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today